Infecção pelo Trichomonas vaginalis em gestantes: patogênese, diagnóstico e tratamento
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Resumo
Objetivo: Reunir informações que abordem as alterações decorrentes da infecção pelo Trichomonas vaginalis em mulheres grávidas. Métodos: Trata-se de uma pesquisa descritiva, qualitativa. A busca de artigos foi feita nas seguintes bases de dados: SCIELO, PUBMED e LILACS, utilizando os descritores: “Saúde da Mulher”; “Tricomoníase”; “Complicações infecciosas na gravidez”. Foram incluídos artigos científicos publicados de janeiro de 2018 a outubro de 2023, em inglês, português e espanhol e que apresentassem conteúdo relevante para o tema. Ao final da análise, restaram 26 artigos para serem incluídos no presente estudo. Resultados: A tricomoníase está associada com resultados adversos no parto. Na rede pública do Brasil, o diagnóstico não é realizado pela identificação do agente etiológico e o manejo ocorre de modo sindrômico. Existem diferentes respostas das mulheres ao mesmo tipo de alteração na microbiota vaginal. Para diagnosticar a doença, métodos por amplificação de ácidos nucleicos fornecem resultados mais precisos e o tratamento é realizado com metronidazol via oral, medicamento seguro na gestação. Considerações finais: É necessário que mais estudos sejam realizados no Brasil para avaliação da necessidade de rastreio de algumas doenças infecciosas em gestantes tais como a tricomoníase.
##plugins.themes.bootstrap3.article.details##
Copyright © | Todos os direitos reservados.
A revista detém os direitos autorais exclusivos de publicação deste artigo nos termos da lei 9610/98.
Reprodução parcial
É livre o uso de partes do texto, figuras e questionário do artigo, sendo obrigatória a citação dos autores e revista.
Reprodução total
É expressamente proibida, devendo ser autorizada pela revista.
Referências
2. ASRES AW, et al. Prevalence and trends of sexually transmitted infections among pregnant women in Mizan Tepi University Teaching Hospital, Southwest Ethiopia: a cross-sectional study. The Pan African medical jornal, 2022; 42: 111.
3. BAGGA R, ARORA P. Genital Micro-Organisms in Pregnancy. Frontiers in Public Health, 2020; 8: 225.
4. BAQUI AH, et al. Prevalence of and risk factors for abnormal vaginal flora and its association with adverse pregnancy outcomes in a rural district in north-east Bangladesh. Acta obstetricia et gynecologica Scandinavica, 2019; 98(3): 309-319.
5. BRASIL. Ministério da Saúde. Protocolo Clínico e Diretrizes Terapêuticas para Atenção Integral às Pessoas com Infecções Sexualmente Transmissíveis (IST). 2022. Disponível em: https://www.gov.br/aids/pt-br/centrais-de-conteudo/pcdts/2022/ist/pcdt-ist-2022_isbn-1.pdf/view. Acessado em: 5 de outubro de 2023.
6. BRUNHAM RC e PAAVONEN J. Reproductive system infections in women: upper genital tract, fetal, neonatal and infant syndromes. Pathogens and Disease, 2020; 78(5): ftaa023.
7. DIONNE-ODOM J, et al. HIV Status and Other Risk Factors for Prevalent and Incident Sexually Transmitted Infection during Pregnancy (2000-2014). Infectious Diseases in Obstetrics and Gynecology, 2019; 2019: 1-8.
8. GRANT JS, et al. Sexually Transmitted Infections in Pregnancy: A Narrative Review of the Global Research Gaps, Challenges, and Opportunities. Sexually Transmitted Diseases, 2020; 47(12): 779-789.
9. HILLIER SL, et al. Diagnosis and Treatment of Vaginal Discharge Syndromes in Community Practice Settings. Clinical Infectious Diseases, 2020; 72(9): 1538–1543.
10. HUSAIN S, et al. Effects of oral probiotic supplements on vaginal microbiota during pregnancy: a randomised, double-blind, placebo-controlled trial with microbiome analysis. BJOG: an international journal of obstetrics and gynaecology, 2019; 127(2): 275-284.
11. JARRETT OD, et al. Specific Vaginal Bacteria Are Associated With an Increased Risk of Trichomonas vaginalis Acquisition in Women. The Journal of Infectious Diseases, 2019; 220(9): 1503-1510.
12. KALIA N, et al. Microbiota in vaginal health and pathogenesis of recurrent vulvovaginal infections: a critical review. Annals of Clinical Microbiology and Antimicrobials, 2020; 19(1): 5.
13. KIM TG, et al. Trichomonas vaginalis in Pregnancy: Patterns and Predictors of Testing, Infection, and Treatment. Obstetrics & Gynecology, 2020; 135(5): 1136-1144.
14. LEE ACC, et al. Effect of population-based antenatal screening and treatment of genitourinary tract infections on birth outcomes in Sylhet, Bangladesh (MIST): a cluster-randomised clinical trial. The Lancet Global Health, 2019; 7(1): e148–e159.
15. LILLIS RA, et al. Clinical Evaluation of a New Molecular Test for the Detection of Organisms Causing Vaginitis and Vaginosis. Journal of Clinical Microbiology, 2023; 61(3): e0174822.
16. NYEMBA DC, et al. Impact of aetiological screening of sexually transmitted infections during pregnancy on pregnancy outcomes in South Africa. BMC pregnancy and childbirth, 2022; 22(1): 194.
17. ODAGAMI M, et al. Awareness of Infectious Disease Screening During Early Pregnancy and Knowledge About its Vertical Transmission in Japan: A Report from the Pregnant Women Health Initiative. Maternal and Child Health Journal, 2023; 27(5): 933-943.
18. OP DE COUL ELM, et al. Chlamydia trachomatis, Neisseria gonorrhoea, and Trichomonas vaginalis infections among pregnant women and male partners in Dutch midwifery practices: prevalence, risk factors, and perinatal outcomes. Reproductive Health, 2021; 18(1): 132.
19. PALMA C, et al. Cribado de infecciones cervicales de transmisión sexual en mujeres embarazadas y su relación con la microbiota vaginal. Revista chilena de infectología, 2019; 36(3): 292-298.
20. RAJABPOUR M, et al. Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis among women with genitourinary infection and pregnancy-related complications in Tehran: A cross-sectional study. International Journal of STD & AIDS, 2020; 31(8): 773-780.
21. SHANNON CL, et al. Acceptability and Feasibility of Rapid Chlamydial, Gonococcal, and Trichomonal Screening and Treatment in Pregnant Women in 6 Low- to Middle-Income Countries. Sexually transmitted diseases, 2018; 45(10): 673-676.
22. TEASDALE CA, et al. Incidence of sexually transmitted infections during pregnancy. PloS one, 2018; 13(5): e0197696.
23. THI TRUNG THU T, et al. Trichomonas vaginalis Transports Virulent Mycoplasma hominis and Transmits the Infection to Human Cells after Metronidazole Treatment: A Potential Role in Bacterial Invasion of Fetal Membranes and Amniotic Fluid. Journal of pregnancy, 2018; 2018:5037181.
24. WARR AJ, et al. Sexually transmitted infections during pregnancy and subsequent risk of stillbirth and infant mortality in Kenya: a prospective study. Sexually transmitted infections, 2019; 95(1): 60-66.
25. WYNN A, et al. Prevalence and treatment outcomes of routine Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis testing during antenatal care, Gaborone, Botswana. Sexually Transmitted Infections, 2018; 94(3): 230-235.
26. WINN A, et al. Using partner notification to address curable sexually transmitted infections in a high HIV prevalence context: a qualitative study about partner notification in Botswana. BMC public health, 2019; 19(1): 606.
27. YEGANEH N, et al. Diagnosis and treatment of sexually transmitted infections in male partners of pregnant women in Brazil. International journal of STD & AIDS, 2021; 32(13): 1242-1249.